Australia markets closed

Exopharm Limited (EX1.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.01100.0000 (0.00%)
At close: 11:10AM AEDT
Currency in AUD

Valuation measures4

Market cap (intra-day) 4.83M
Enterprise value 4.72M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.50
Price/book (mrq)1.17
Enterprise value/revenue 7.64
Enterprise value/EBITDA -0.93

Trading information

Stock price history

Beta (5Y monthly) 1.24
52-week change 3-85.71%
S&P500 52-week change 314.91%
52-week high 30.0790
52-week low 30.0080
50-day moving average 30.0110
200-day moving average 30.0110

Share statistics

Avg vol (3-month) 3101.25k
Avg vol (10-day) 3N/A
Shares outstanding 5439.42M
Implied shares outstanding 6439.42M
Float 8318.98M
% held by insiders 138.21%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)30 June 2023


Profit margin -210.14%
Operating margin (ttm)-224.31%

Management effectiveness

Return on assets (ttm)-43.71%
Return on equity (ttm)-110.25%

Income statement

Revenue (ttm)3.39M
Revenue per share (ttm)0.02
Quarterly revenue growth (yoy)-72.40%
Gross profit (ttm)28.17k
Net income avi to common (ttm)-7.13M
Diluted EPS (ttm)-0.0400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.64M
Total cash per share (mrq)0
Total debt (mrq)1.53M
Total debt/equity (mrq)37.16%
Current ratio (mrq)2.67
Book value per share (mrq)0.01

Cash flow statement

Operating cash flow (ttm)-3.85M
Levered free cash flow (ttm)-2.18M